Clinical Trial Update: Ketamine for Multiple Sclerosis Fatigue [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ketamine for fatigue in people with multiple sclerosis; currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Johns Hopkins University | Conditions: Multiple Sclerosis Fatigue | Phase 2 | Status: ACTIVE_NOT_RECRUITING